Homeostasis and its disruption in the lung microbiome

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 309, Issue 10, 2015, Pages L1047-L1055

  Dickson, Robert P ^a   Erb Downward, John R ^a   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

16S; Culture independent; Ecology; Equilibrium; Homeostasis; Lung; Microbial ecology; Physiology; Pulmonary

Indexed keywords

CELLULAR STRESS RESPONSE; CHRONIC LUNG DISEASE; FEEDBACK SYSTEM; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; MICROBIOME; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THEORETICAL MODEL; ANIMAL; IMMUNOLOGY; LUNG; LUNG DISEASE; METABOLISM; MICROBIOLOGY; MICROFLORA; ORGANISMAL INTERACTION; PHYSIOLOGY;

ANIMALS; HOMEOSTASIS; HUMANS; LUNG; LUNG DISEASES; MICROBIAL INTERACTIONS; MICROBIOTA; SIGNAL TRANSDUCTION;

EID: 84947215987     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00279.2015     Document Type: Review

References (58)

1. Amberson JB. A clinical consideration of abscesses and cavities of the lung. Bull Johns Hopkins Hosp 94: 227–237, 1954.
2. Andersson SGE, Zomorodipour A, Andersson JO, Sicheritz-Ponten T, Alsmark UCM, Podowski RM, Naslund AK, Eriksson AS, Winkler HH, Kurland CG. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 396: 133–140, 1998.
3. Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM, Young VB, Beck JM, Curtis JL, Huffnagle GB. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio 6: 2015.
4. Bernard C. Leçons sur les pheínomeÌnes de la vie communs aux animaux et veígeítaux. Paris: Baillere, 1878.
5. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 184: 957–963, 2011.
6. Crespi BJ. Vicious circles: positive feedback in major evolutionary and ecological transitions. Trends Ecol Evol 19: 627–633, 2004.
7. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559–563, 2014.
8. Dickson RP, Erb-Downward JR, Freeman CM, McCloskey L, Beck JM, Huffnagle GB, Curtis JL. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc 12: 821–830, 2015.
9. Dickson RP, Erb-Downward JR, Freeman CM, Walker N, Scales BS, Beck JM, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS One 9: e97214, 2014.
10. Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 7: 245–257, 2013.
11. Dickson RP, Erb-Downward JR, Huffnagle GB. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med 2: 238–246, 2014.
12. Dickson RP, Erb-Downward JR, Prescott HC, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol 52: 3605–3613, 2014.
13. Dickson RP, Erb-Downward JR, Prescott HC, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. Intraalveolar catecholamines and the human lung microbiome. Am J Respir Crit Care Med 192: 257–259, 2015.
14. Dickson RP, Huffnagle GB. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS Pathog 11: e1004923, 2015.
15. Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet 384: 691–702, 2014.
16. Dixon KR, Cornwell GW. A mathematical model for predator and prey populations. Res Popul Ecol 12: 127–136, 1970.
17. Edgell DR, Doolittle WF. Archaea and the origin (s) of DNA replication proteins. Cell 89: 995–998, 1997.
18. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One 6: e16384, 2011.
19. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM, Gao H, Van Rooijen N, Huber-Lang MS, Neubig RR, Ward PA. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449: 721–725, 2007.
20. Freestone P. Communication between bacteria and their hosts. Scientifica (Cairo) 2013: 15, 2013.
21. Freestone PP, Haigh RD, Williams PH, Lyte M. Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiol Lett 172: 53–60, 1999.
22. Freestone PP, Hirst RA, Sandrini SM, Sharaff F, Fry H, Hyman S, O’Callaghan C. Pseudomonas aeruginosa-catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia? Chest 142: 1200–1210, 2012.
23. Freestone PP, Sandrini SM, Haigh RD, Lyte M. Microbial endocrinology: how stress influences susceptibility to infection. Trends Microbiol 16: 55–64, 2008.
24. Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest 111: 1266–1272, 1997.
25. Goddard AF, Staudinger BJ, Dowd SE, Joshi-Datar A, Wolcott RD, Aitken ML, Fligner CL, Singh PK. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci USA 109: 13769–13774, 2012.
26. Günther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176–184, 1996.
27. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, Moffatt MF, Cookson WO. Disordered microbial communities in asthmatic airways. PLoS One 5: e8578, 2010.
28. Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 64:564–568,1978.
29. Ingenito EP, Solway J, McFadden ER Jr, Pichurko B, Bowman HF, Michaels D, Drazen JM. Indirect assessment of mucosal surface temperatures in the airways: theory and tests. J Appl Physiol 63: 2075–2083, 1987.
30. Kanangat S, Meduri GU, Tolley EA, Patterson DR, Meduri CU, Pak C, Griffin JP, Bronze MS, Schaberg DR. Effects of cytokines and endotoxin on the intracellular growth of bacteria. Infect Immun 67: 2834–2840, 1999.
31. Kaza SK, McClean S, Callaghan M. IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Int J Med Microbiol 301: 26–33, 2011.
32. Lighthart B. Mini-review of the concentration variations found in the alfresco atmospheric bacterial populations. Aerobiologia 16: 7–16, 2000.
33. Lozupone C, Cota-Gomez A, Palmer BE, Linderman DJ, Charlson ES, Sodergren E, Mitreva M, Abubucker S, Martin J, Yao G, Campbell TB, Flores SC, Ackerman G, Stombaugh J, Ursell L, Beck JM, Curtis JL, Young VB, Lynch SV, Huang L, Weinstock GM, Knox KS, Twigg H, Morris A, Ghedin E, Bushman FD, Collman RG, Knight R, Fontenot AP. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med 187: 1110–1117, 2013.
34. Lyte M, Ernst S. Catecholamine induced growth of gram negative bacteria. Life Sci 50: 203–212, 1992.
35. Lyte M, Freestone PP. Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health. New York: Springer Science+Business Media, 2010.
36. MacArthur RH, Wilson EO. An equilibrium theory of insular zoogeography. Evolution 373–387, 1963.
37. Marks LR, Davidson BA, Knight PR, Hakansson AP. Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. mBio 4: 2013.
38. Monton C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 27: 1745–1753, 1999.
39. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, Jablonski K, Kleerup E, Lynch SV, Sodergren E, Twigg H, Young VB, Bassis CM, Venkataraman A, Schmidt TM, Weinstock GM. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 187: 1067–1075, 2013.
40. O’Donnell PM, Aviles H, Lyte M, Sonnenfeld G. Enhancement of in vitro growth of pathogenic bacteria by norepinephrine: importance of inoculum density and role of transferrin. Appl Environ Microbiol 72: 5097–5099, 2006.
41. Pickett STA, White PS. The Ecology of Natural Disturbance and Patch Dynamics. San Diego: Academic, 1985.
42. Plotkin BJ, Roose RJ, Erikson Q, Viselli SM. Effect of androgens and glucocorticoids on microbial growth and antimicrobial susceptibility. Curr Microbiol 47: 514–520, 2003.
43. Porat R, Clark BD, Wolff SM, Dinarello CA. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 254: 430–432, 1991.
44. Poroyko V, Meng F, Meliton A, Afonyushkin T, Ulanov A, Semenyuk E, Latif O, Tesic V, Birukova AA, Birukov KG. Alterations of lung microbiota in a mouse model of LPS-induced lung injury. Am J Physiol Lung Cell Mol Physiol 309: L76–L83, 2015.
45. Quinn LH, Meyer OO. The relationship of sinusitis and bronchiectasis. Arch Otolaryngol 10: 152–165, 1929.
46. Redfield AC. On the proportions of organic derivatives in sea water and their relation to the composition of plankton. In: James Johnstone Memorial Volume. Liverpool, UK: University Press of Liverpool, 1934.
47. Sandrini S, Aldriwesh M, Alruways M, Freestone P. Microbial endocrinology: host-bacteria communication within the gut microbiome. J Endocrinol 225: R21–R34, 2015.
48. Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Chen H, Berger KI, Goldring RM, Rom WN, Blaser MJ, Weiden MD. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1: 19, 2013.
49. Shapiro JA. Evolution: A View From the 21st Century. Upper Saddle River, NJ: FT Press Science, 2011.
50. Sibley CD, Rabin H, Surette MG. Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol 1: 53–61, 2006.
51. Sunda WG, Graneli E, Gobler CJ. Positive feedback and the development and persistence of ecosystem disruptive algal blooms. J Phycol 42: 963–974, 2006.
52. Thurber RV. Current insights into phage biodiversity and biogeography. Curr Opin Microbiol 12: 582–587, 2009.
53. Venkataraman A, Bassis CM, Beck JM, Young VB, Curtis JL, Huffnagle GB, Schmidt TM. Application of a neutral community model to assess structuring of the human lung microbiome. mBio 6: 2015.
54. Volterra V. Fluctuations in the abundance of a species considered mathematically. Nature 118: 558–560, 1926.
55. West JB. Regional differences in the lung. Chest 74: 426–437, 1978.
56. Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, Rainey PB, Rohwer F, Conrad D. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J 6: 471–474, 2012.
57. Zaborina O, Lepine F, Xiao G, Valuckaite V, Chen Y, Li T, Ciancio M, Zaborin A, Petroff E, Turner JR, Rahme LG, Chang E, Alverdy JC. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog 3: e35, 2007.
58. Zhang X, Essmann M, Burt ET, Larsen B. Estrogen effects on Candida albicans: a potential virulence-regulating mechanism. J Infect Dis 181: 1441–1446, 2000.